Name | Recombinant Mouse TNF RI/TNFRSF1A Fc Chimera Protein, CF |
---|---|
Supplier | R&D Systems |
Catalog | 430-RI/CF |
Category | Protein |
Prices | $329.00 |
Sizes | 50 µg |
Species Reactivities | Mouse |
Nature | Recombinant |
Source | Mouse myeloma cell line, NS0-derived Mouse TNF RI (Leu30-Ala212) Accession # P25118 DIEGRMD Human IgG 1 (Pro100-Lys330) 6-His tag N-terminus C-terminus |
Purity | >90%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Bioactivity | Measured by its ability to inhibit the TNF-alpha mediated cytotoxicity in the L‑929 mouse fibroblast cells in the presence of the metabolic inhibitor actinomycin D. Matthews, N. and M.L. Neale (1987) in Lymphokines and Interferons, A Practical Approach. Clemens, M.J. et al . (eds): IRL Press. 221. The ED 50 for this effect is 0.5-2.0 ng/mL in the presence of 0.1 ng/mL recombinant mouse TNF-alpha. |
Endotoxin | <0.10 EU per 1 μg of the protein by the LAL method. |
SwissProt/Accession | P25118 |
Gene | Tnfrsf1a |
Sequence | Leu30 |
Supplier Page | Shop |
Pontejo SM, Alejo A, Alcami A. J Biol Chem. 2015 Jun 26;290(26):15973-84.
Goodall LJ, Ovecka M, Rycroft D, Friel SL, Sanderson A, Mistry P, Davies ML, Stoop AA. PLoS One. 2015 Sep 9;10(9):e0137065.
Bruggeman LA, Drawz PE, Kahoud N, Lin K, Barisoni L, Nelson PJ. Lab Invest. 2011 Mar;91(3):413-25.